Preoperative characteristics | Perioperative and postoperative characteristics | ||
---|---|---|---|
Age (yr) | 66 ± 10 | Use of intra-aortic balloon (%) | 6.3 |
Female (%) | 25 | Heart valve surgery (%) | 23 |
Caucasian (%) | 94 | CABG (%) | 93 |
Active smoking status (%) | 27 | Duration of ECC (hr) (IQR) | 1.1 (0.9 to 1.5) |
Initial GFR (ml/min/1.73 m2) | 72 ± 19 | Urgent surgery (%) | 14 |
Comorbidities | Reintervention (%) | 4 | |
Hypertension (%) | 72 | Postoperative cardiovascular SOFA score ≤2, >2 (%) | 51, 49 |
Diabetes (%) | 31 | Perioperative transfusions | |
Hyperlipidemia (%) | 69 | Red blood cells (0, 1, 2, ≥3 U) (%) | 45, 15, 14, 22 |
Peripheral vascular disease (%) | 8 | Platelets (0, ≤10, >10 U) (%) | 80, 17, 3 |
Stroke (%) | 7 | Fresh frozen plasma (0, ≤5, >5 U) (%) | 80, 16, 4 |
MI within the past 7 days (%) | 13 | ||
LVEF ≤35%, 36% to 49%, ≥50% (%) | 9, 14, 77 | AKI (%) | |
Drugs used within 5 days prior to surgery | AKIN stage 1 | 12.0 | |
Diuretics (%) | 34 | RIFLE risk | 5.3 |
RASB (%) | 59 | RIFLE injury | 1.9 |
NSAIDs (%) | 9 | RIFLE failure | 0.7 |
Contrast agent for angiography (%) | 26 | ||
Preoperative hemoglobin (g/L) | 130 ± 17 |